[go: up one dir, main page]

IL105101A0 - Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist - Google Patents

Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist

Info

Publication number
IL105101A0
IL105101A0 IL105101A IL10510193A IL105101A0 IL 105101 A0 IL105101 A0 IL 105101A0 IL 105101 A IL105101 A IL 105101A IL 10510193 A IL10510193 A IL 10510193A IL 105101 A0 IL105101 A0 IL 105101A0
Authority
IL
Israel
Prior art keywords
interleukin
induce
production
receptor antagonist
antagonist
Prior art date
Application number
IL105101A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL105101A0 publication Critical patent/IL105101A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL105101A 1992-03-20 1993-03-18 Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist IL105101A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85455392A 1992-03-20 1992-03-20

Publications (1)

Publication Number Publication Date
IL105101A0 true IL105101A0 (en) 1993-07-08

Family

ID=25319015

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105101A IL105101A0 (en) 1992-03-20 1993-03-18 Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist

Country Status (5)

Country Link
CN (1) CN1081378A (fr)
AU (1) AU3801193A (fr)
IL (1) IL105101A0 (fr)
WO (1) WO1993018783A1 (fr)
ZA (1) ZA931942B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
JPH08510719A (ja) * 1993-02-01 1996-11-12 ユニヴェルシテ リブル ドゥ ブリュッセル アンスティテュション ダンセニュマン ユニヴェルシテル 有効量のインターロイキン−１０、その類似体および／または作動薬を含有する医薬組成物の使用
AU6887096A (en) * 1996-09-11 1998-04-02 Patrick T. Prendergast Immune direction therapy
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US6544504B1 (en) 1999-07-28 2003-04-08 Schering Corporation Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
AU6376700A (en) * 1999-07-28 2001-02-19 Schering Corporation Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
WO2002066069A1 (fr) * 2001-02-20 2002-08-29 Kansai Technology Licensing Organization Co., Ltd. Remedes contre l'inflammation/les maladies tumorales

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
EP0506836B1 (fr) * 1989-12-20 1994-09-28 Schering Corporation PROTEINES BCRF1 EN TANT QU'INHIBITEURS D'INTERFERON-$g(g)
ES2138976T3 (es) * 1991-08-06 2000-02-01 Schering Corp Uso de analogos o antagonistas de interleucina-10 para tratar la toxicidad inducida por endotoxinas o superantigenos.

Also Published As

Publication number Publication date
ZA931942B (en) 1993-09-29
CN1081378A (zh) 1994-02-02
WO1993018783A1 (fr) 1993-09-30
AU3801193A (en) 1993-10-21

Similar Documents

Publication Publication Date Title
GB2266458B (en) Use of 3-hydroxypyridin-4-ones as selective therapeutics
GB9111674D0 (en) Structure of fastening device for fastening two things together
GB2260774B (en) Improvements to gutters
GB2264948B (en) Human adenosine receptors
AU1916192A (en) Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs
ZA931942B (en) Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist
GB8716152D0 (en) Adjustable centre rod structure
GB9011544D0 (en) Improvements relating to support structures
GB9226115D0 (en) Improvements relating to bed converings
GB8912606D0 (en) Improvements relating to joint support devices
GB9222985D0 (en) Use of the tarchonanthus camphoratus
ZA898936B (en) Use of benzomorphanes for cytoprotection
GR3000924T3 (en) Shower rod
ZA892672B (en) Use of tp-receptor antagonists to modify the action of myofibroblasts
GB2255797B (en) Improvements relating to the lining of troughs
IL86357A (en) Continuous process for the preparation of dibromomethane
GB8805954D0 (en) Range conversion unit
GB2256420B (en) Improvements relating to fibre-wound structures
GB2262984B (en) Conversion of points to lines
PL101183U1 (en) Structure for use to restore vertical position of inclined buildings
SU1593324A1 (ru) Teлeckoпичeckaя пpoctpahctbehhaя kohctpуkция
SG99826A1 (en) Rashaped human antibody to human interleukin-6 receptor
ZA888852B (en) Interleukin-1 receptors
ZA937506B (en) Hetrocyclic-esters or amides used as 5-HT4 receptor antagonists
GB8813107D0 (en) Purification of aluminium